Document Detail


Location of acute brain hemorrhage in patients undergoing antithrombotic therapy.
MedLine Citation:
PMID:  19254798     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: The relationship between antithrombotic therapy and the anatomical location of acute brain hematoma remains disputed. The current study was therefore designed to address this issue. METHODS: The medical records and CT images were retrospectively reviewed in 484 consecutive patients with an acute brain hemorrhage (291 men, 193 women; mean age, 67.2+/-12.3 years) who were admitted to the hospital within 7 days of stroke onset from January 1999 through October 2003. Antithrombotic therapy had been performed in 116 patients (AT Group): warfarin (n=38), antiplatelet therapy (n=70), or both (n=8). The other 368 patients had not received antithrombotic therapy (non-AT Group). The hematoma location was compared among the groups. RESULTS: The location of the hematoma was significantly different between the two groups (p<0.0001). The following locations were seen more frequently in the AT Group than in the non-AT Group: thalamic hemorrhage (44.8% vs. 30.7%), cerebellar hemorrhage (7.8% vs. 2.7%), and lobar hemorrhage (18.1% vs. 11.4%). The clinical characteristics in patients with thalamic, cerebellar, or lobar hemorrhage were compared with those with putaminal hemorrhage. A multivariate analysis using the logistic regression model showed that antithrombotic therapy was an independent factor for cerebellar hemorrhage (OR 3.66, 95%CI 1.31-10.18), lobar hemorrhage (OR 2.27, 95%CI 1.12-4.57), and thalamic hemorrhage (OR 2.20, 95%CI 1.06-4.54) in comparison to putaminal hemorrhage. CONCLUSIONS: It therefore appears that antithrombotic therapy is independently associated with thalamic, cerebellar, and lobar hemorrhage.
Authors:
Ryo Itabashi; Masahiro Yasaka; Takahiro Kuwashiro; Hideaki Nakagaki; Fumio Miyashita; Hiroaki Naritomi; Kazuo Minematsu
Related Documents :
23294118 - Durability of the anti-erosive effect of surfaces sealants under erosive abrasive condi...
23391948 - Uterine rupture complicating sequential curettage and bakri balloon tamponade to contro...
24635858 - Total lower lip reconstruction with a double mental neurovascular v-y island advancemen...
9555638 - Endovascular treatment of pial avms: technical options, indications and limits in pedia...
24144788 - Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: in...
7682268 - Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline ...
Publication Detail:
Type:  Journal Article     Date:  2009-02-28
Journal Detail:
Title:  Journal of the neurological sciences     Volume:  280     ISSN:  1878-5883     ISO Abbreviation:  J. Neurol. Sci.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-04-06     Completed Date:  2009-08-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375403     Medline TA:  J Neurol Sci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  87-9     Citation Subset:  IM    
Affiliation:
Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan. ritabash@kohnan-sendai.or.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Brain / drug effects,  pathology
Female
Fibrinolytic Agents / therapeutic use*
Humans
Intracranial Hemorrhages / drug therapy*,  pathology*
Logistic Models
Male
Multivariate Analysis
Platelet Aggregation Inhibitors / therapeutic use*
Risk Factors
Tomography, X-Ray Computed
Warfarin / therapeutic use*
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; 0/Platelet Aggregation Inhibitors; 81-81-2/Warfarin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Typical and atypical development of basic numerical skills in elementary school.
Next Document:  Ecdysteroids and a sucrose phenylpropanoid ester from Froelichia floridana.